The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients
Supportive Care in Cancer, 01/24/2011
Warmenhoven F et al.
– The aim of this study was to determine the validity of the Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in advanced cancer patients.
Patients with advanced metastatic disease, visiting outpatient palliative care department, asked to fill out self-questionnaire containing Beck Depression Inventory (BDI-II) and single screening question “Are you feeling depressed?”
Mood section of PRIME-MD used as gold standard
61 patients with advanced metastatic disease eligible to be included in the study
Complete data obtained from 46 patients
Area under curve of receiver operating characteristics analysis of BDI-II was 0.82
Optimal cut-off point of BDI-II was 16 with sensitivity of 90% and specificity of 69%
Single screening question showed sensitivity of 50% and specificity of 94%
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.